|
Çѱ¹Á¦¾à»ê¾÷¿¬±¸¼Ò(The Pharmaceutical Advanced Institute of Korea; KPAI, ÇÑÁ¦¿¬)´Â Ãֽоà»ç¹ý·É°ú º¸ÇèÀǾàǰ °ü·Ã °Ç°º¸Çè¹ý·É µîÀ» ¼ö·ÏÇÑ Á¦¾à ¹ý·É ÇÚµåºÏÀÎ ‘2017 PCB¿Í PPRS’¸¦ ¿À´Â 3¿ù29ÀÏ ¹ß°£Çϰí ȸ¿ø»çµé°ú »çÀü ÁÖ¹®Àڵ鿡°Ô ¹èÆ÷ÇÑ´Ù°í 2ÀÏ ¹àÇû´Ù.
‘2017 PCB & PPRS`´Â ÀǾàǰ °³¹ß°ú °ü·ÃÇÑ ½Ç¹«Àڵ鿡°Ô ÇÊ¿äÇÑ ±¹³» ¹ý·ÉÀ» ÈÞ´ëÇÏ±â Æí¸®ÇÏ°Ô ÇÚµåºÏ ÇüÅ·ΠÁ¦ÀÛÇÑ °ÍÀ¸·Î PCB(Pharmaceutical Code Book)´Â ¾à»ç¹ý °ü·Ã ¹ý·É°ú ±ÔÁ¤ÁýÀ¸·Î PPRS(Pharmaceutical Pricing Regulation Scheme)´Â ÀǾàǰ °¡°Ý°ú À¯Åë °ü·Ã ±ÔÁ¤°ú Á¦¾à»ê¾÷ Á¤Ã¥À» Æ÷ÇÔÇØ ¹ßÇàµÈ´Ù.
À̹ø¿¡ ¹ßÇàµÇ´Â ‘PCB(Pharmaceutical Code Book)’¿¡´Â Áö³ÇØ Á¦Á¤µÈ ÀǾàǰ ǰ¸ñ °»½Å¿¡ °üÇÑ ±ÔÁ¤À» Æ÷ÇÔÇØ ÀǾàǰ À§Çؼº °ü¸® °èȹ ¾÷¹« °¡À̵å¶óÀÎÀÌ °ÔÀçµÆ´Ù.
PPRS(Pharmaceutical Pricing Regulation Scheme)´Â ÀÇ·á¹ý, ºÎÁ¤Ã»Å¹±ÝÁö¹ý µî 28°³ ¹ý·É°ú ÁöħµéÀ» »õ·Ó°Ô ´ëÆø Ãß°¡Çؼ ¿µ¾÷Àº ¹°·Ð ¸¶ÄÉÆÃ ´ã´çÀڵ鵵 Ȱ¿ëÇÒ¼ö ÀÖ´Ù. |